News Release

7,000 Pharmaceutical scientists to share latest drug developments and discoveries

Meeting Announcement

American Association of Pharmaceutical Scientists

AAPS Annual Meeting Takes Place in New Orleans, November 14-18

ALEXANDRIA, Va.-- More than 7,000 pharmaceutical scientists will gather in New Orleans, November 14-18 at the 1999 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, The Quest for the Magic Bullet: An Outstanding Century. Scientists from around the world will share the latest developments in the field of pharmaceutical research and development.

"The AAPS Annual Meeting is the largest gathering of pharmaceutical scientists worldwide," said AAPS President Larry Augsburger, Ph.D. "Scientists at this meeting will present more than 2,500 contributed papers featuring important scientific findings."

The plenary session, "The Quest for the Magic Bullet: An Outstanding Century," takes place on Nov. 15, 8:30 a.m. - 12:00 p.m. The session will reflect on outstanding achievements in the pharmaceutical sciences during the 20th Century and examine how recent advances in research, development and technology will lead the pharmaceutical sciences into the next century.

"The plenary session promises to provide a glimpse into the future of drug therapy and health care and a recap of the most significant advances made in the pharmaceutical sciences over the past century," said AAPS Annual Meeting Program Chair Jay Sisco, Ph.D.

The meeting will offer nine short courses, 17 roundtables and 43 symposium sessions, which focus on topics such as the future of genetic immunization, recent developments in drug delivery and targeting, advances in vaccines, emerging analytical/bioanalytical techniques, particle engineering and modeling techniques, and competition in a patient-driven market.

Meeting highlights include:

  • 61623: Jane E. Henney, M.D., Commissioner of the Food and Drug Administration, will deliver the keynote address at the meeting's opening session on Nov. 14. Dr. Henney will outline her vision for the FDA as the agency enters the new millennium.

  • 61623: An open hearing, entitled "The Role of Pharmaceutical Science in Providing Guidance on the Quality of Dietary Supplements and Nutraceuticals," will take place November 16, 1:30 p.m. - 4:00 p.m. In this session, key leaders in the area of herbal dietary supplements will speak on "The Impact of the 1995 Dietary Health and Education Act in Providing Faster Access to the Marketplace," "Tapping into the Medical Benefits of Nutraceuticals," and "Separating Market Hype from Medical Helpfulness." A panel discussion with audience participation will focus on the role that pharmaceutical sciences should play in providing assurance of the quality and consistency of nutraceutical products.
More than 350 companies will exhibit at this year's Exposition, November 15-17 at the Ernest N. Morial Convention Center in New Orleans. Exhibiting companies are involved in areas such as contract manufacturing, drug delivery systems, drug development, and laboratory instruments and equipment.

###

For detailed information about the meeting and overviews of the presentations, visit AAPS Online at www.aaps.org. For press registration information, contact Alisa Cahan by phone at 305-573-9955 or e-mail at cahan@nixongroup.com.

Editor's Note: In early September, abstracts of the papers to be presented at the meeting can be previewed in a fully-searchable database on AAPS Online www.aaps.org

AAPS is a professional, scientific society of more than 9,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and contribute to human health through pharmaceutical research and development. For more information about AAPS, visit AAPS Online at www.aaps.org.



Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.